• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical PET-MR Imaging in Breast Cancer and Lung Cancer.乳腺癌和肺癌的临床正电子发射断层扫描-磁共振成像
PET Clin. 2016 Oct;11(4):387-402. doi: 10.1016/j.cpet.2016.05.008.
2
Breast PET/MR Imaging.乳腺正电子发射断层显像/磁共振成像
Radiol Clin North Am. 2017 May;55(3):579-589. doi: 10.1016/j.rcl.2016.12.011. Epub 2017 Feb 1.
3
PET/MR Imaging for Chest Diseases: Review of Initial Studies on Pulmonary Nodules and Lung Cancers.PET/MR成像在胸部疾病中的应用:肺结节和肺癌的初步研究综述
Magn Reson Imaging Clin N Am. 2015 May;23(2):245-59. doi: 10.1016/j.mric.2015.01.008.
4
Improved Detection of Small Pulmonary Nodules Through Simultaneous MR/PET Imaging.通过同时进行磁共振成像/正电子发射断层扫描成像改善小肺结节的检测
PET Clin. 2018 Jan;13(1):89-95. doi: 10.1016/j.cpet.2017.09.001.
5
PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.PET/MR成像在肺部病变检测与特征描述中的应用:与PET/CT的技术和诊断评估比较
J Nucl Med. 2014 May;55(5):724-9. doi: 10.2967/jnumed.113.129247. Epub 2014 Mar 20.
6
Quantitative PET/MR imaging of lung cancer in the presence of artifacts in the MR-based attenuation correction maps.基于磁共振成像的衰减校正图中存在伪影时肺癌的定量PET/MR成像。
Acta Radiol. 2020 Jan;61(1):11-20. doi: 10.1177/0284185119848118. Epub 2019 May 15.
7
Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET)/MRI for Lung Cancer Staging.用于肺癌分期的磁共振成像(MRI)和正电子发射断层扫描(PET)/MRI
J Thorac Imaging. 2016 Jul;31(4):215-27. doi: 10.1097/RTI.0000000000000210.
8
Integration of PET/MR Hybrid Imaging into Radiation Therapy Treatment.正电子发射断层显像/磁共振成像(PET/MR)混合成像在放射治疗中的应用
Magn Reson Imaging Clin N Am. 2017 May;25(2):377-430. doi: 10.1016/j.mric.2017.01.001.
9
PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.采用诊断性磁共振序列的PET/MRI与PET/CT在腹部和盆腔癌症检测中的比较
Eur J Radiol. 2016 Apr;85(4):751-9. doi: 10.1016/j.ejrad.2016.01.010. Epub 2016 Jan 21.
10
[Multiparametric and molecular imaging of breast tumors with MRI and PET/MRI].[利用MRI和PET/MRI对乳腺肿瘤进行多参数及分子成像]
Radiologe. 2016 Jul;56(7):612-21. doi: 10.1007/s00117-016-0129-3.

引用本文的文献

1
The role of F-FDG PET/MRI in assessing pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: a systematic review and meta-analysis.F-FDG PET/MRI 在评估乳腺癌新辅助化疗病理完全缓解中的作用:系统评价和荟萃分析。
Radiat Oncol. 2024 Nov 19;19(1):164. doi: 10.1186/s13014-024-02507-5.
2
Application of serum Raman spectroscopy combined with classification model for rapid breast cancer screening.血清拉曼光谱结合分类模型在乳腺癌快速筛查中的应用。
Front Oncol. 2023 Oct 26;13:1258436. doi: 10.3389/fonc.2023.1258436. eCollection 2023.
3
Preliminary experiences of PET/MRI in predicting complete response in patients with breast cancer treated with neoadjuvant chemotherapy.PET/MRI预测新辅助化疗治疗的乳腺癌患者完全缓解的初步经验。
Mol Clin Oncol. 2022 Feb;16(2):50. doi: 10.3892/mco.2021.2483. Epub 2021 Dec 24.
4
Recent Advances in Multimodal Molecular Imaging of Cancer Mediated by Hybrid Magnetic Nanoparticles.混合磁性纳米粒子介导的癌症多模态分子成像的最新进展
Polymers (Basel). 2021 Sep 3;13(17):2989. doi: 10.3390/polym13172989.
5
Development and validation of a novel diagnostic model for assessing lung cancer metastasis in a Chinese population based on multicenter real-world data.基于多中心真实世界数据的中国人群肺癌转移评估新型诊断模型的开发与验证
Cancer Manag Res. 2019 Oct 29;11:9213-9223. doi: 10.2147/CMAR.S217970. eCollection 2019.
6
Amyloid precursor protein promotes the migration and invasion of breast cancer cells by regulating the MAPK signaling pathway.淀粉样前体蛋白通过调节 MAPK 信号通路促进乳腺癌细胞的迁移和侵袭。
Int J Mol Med. 2020 Jan;45(1):162-174. doi: 10.3892/ijmm.2019.4404. Epub 2019 Nov 13.
7
A Novel Sonification Approach to Support the Diagnosis of Alzheimer's Dementia.一种支持阿尔茨海默病痴呆诊断的新型可听化方法。
Front Neurol. 2017 Dec 7;8:647. doi: 10.3389/fneur.2017.00647. eCollection 2017.

本文引用的文献

1
Comparison of Whole-Body (18)F FDG PET/MR Imaging and Whole-Body (18)F FDG PET/CT in Terms of Lesion Detection and Radiation Dose in Patients with Breast Cancer.乳腺癌患者全身(18)F FDG PET/MR成像与全身(18)F FDG PET/CT在病灶检测及辐射剂量方面的比较
Radiology. 2016 Oct;281(1):193-202. doi: 10.1148/radiol.2016151155. Epub 2016 Mar 29.
2
The potential of TOF PET-MRI for reducing artifacts in PET images.飞行时间正电子发射断层扫描-磁共振成像(TOF PET-MRI)减少PET图像伪影的潜力。
EJNMMI Phys. 2015 Dec;2(Suppl 1):A77. doi: 10.1186/2197-7364-2-S1-A77.
3
Preoperative staging of non-small cell lung cancer: prospective comparison of PET/MR and PET/CT.非小细胞肺癌的术前分期:PET/MR 与 PET/CT 的前瞻性比较。
Eur Radiol. 2016 Nov;26(11):3850-3857. doi: 10.1007/s00330-016-4255-0. Epub 2016 Feb 16.
4
Standardized Uptake Values from PET/MRI in Metastatic Breast Cancer: An Organ-based Comparison With PET/CT.正电子发射断层显像/磁共振成像(PET/MRI)在转移性乳腺癌中的标准化摄取值:与正电子发射断层显像/计算机断层扫描(PET/CT)的基于器官的比较
Breast J. 2016 May;22(3):264-73. doi: 10.1111/tbj.12569. Epub 2016 Feb 4.
5
Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer.¹⁸F-FDG PET/MRI、¹⁸F-FDG PET/CT、MRI及CT在复发性乳腺癌全身分期中的评估
Eur J Radiol. 2016 Feb;85(2):459-65. doi: 10.1016/j.ejrad.2015.12.010. Epub 2015 Dec 19.
6
Outcome of small lung nodules missed on hybrid PET/MRI in patients with primary malignancy.原发性恶性肿瘤患者中,在PET/MRI融合检查中被漏诊的小肺结节的转归
J Magn Reson Imaging. 2016 Feb;43(2):504-11. doi: 10.1002/jmri.25005. Epub 2015 Jul 20.
7
Whole-body FDG PET-MR oncologic imaging: pitfalls in clinical interpretation related to inaccurate MR-based attenuation correction.全身氟代脱氧葡萄糖正电子发射断层显像-磁共振成像肿瘤学成像:与基于磁共振的衰减校正不准确相关的临床解读陷阱
Abdom Imaging. 2015 Aug;40(6):1374-86. doi: 10.1007/s00261-015-0455-3.
8
Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT Imaging.¹⁸F-NaF与¹⁸F-FDG联合给药用于PET/CT成像的生物分布半定量分析
J Nucl Med. 2015 May;56(5):688-94. doi: 10.2967/jnumed.115.153767. Epub 2015 Apr 3.
9
Three-way Comparison of Whole-Body MR, Coregistered Whole-Body FDG PET/MR, and Integrated Whole-Body FDG PET/CT Imaging: TNM and Stage Assessment Capability for Non-Small Cell Lung Cancer Patients.全身 MRI、同机融合全身 18F-FDG PET/MR 与全身 18F-FDG PET/CT 成像的三方比较:非小细胞肺癌患者的 TNM 和分期评估能力。
Radiology. 2015 Jun;275(3):849-61. doi: 10.1148/radiol.14140936. Epub 2015 Jan 14.
10
Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in lymph node metastases of non-small cell lung cancer (NSCLC) patients using hybrid 18F-FDG PET/MRI.使用混合18F-FDG PET/MRI对非小细胞肺癌(NSCLC)患者淋巴结转移灶中表观扩散系数(ADC)与标准化摄取值(SUV)的相关性研究。
PLoS One. 2015 Jan 9;10(1):e0116277. doi: 10.1371/journal.pone.0116277. eCollection 2015.

乳腺癌和肺癌的临床正电子发射断层扫描-磁共振成像

Clinical PET-MR Imaging in Breast Cancer and Lung Cancer.

作者信息

Rice Samuel L, Friedman Kent P

机构信息

Division of Nuclear Medicine, Department of Radiology, New York University Langone Medical Center, 660 First Avenue, New York, NY 10016, USA.

Division of Nuclear Medicine, Department of Radiology, New York University Langone Medical Center, 660 First Avenue, New York, NY 10016, USA.

出版信息

PET Clin. 2016 Oct;11(4):387-402. doi: 10.1016/j.cpet.2016.05.008.

DOI:10.1016/j.cpet.2016.05.008
PMID:27593245
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5538357/
Abstract

Hybrid imaging systems have dramatically improved thoracic oncology patient care over the past 2 decades. PET-MR imaging systems have the potential to further improve imaging of thoracic neoplasms, resulting in diagnostic and therapeutic advantages compared with current MR imaging and PET-computed tomography systems. Increasing soft tissue contrast and lesion sensitivity, improved image registration, reduced radiation exposure, and improved patient convenience are immediate clinical advantages. Multiparametric quantitative imaging capabilities of PET-MR imaging have the potential to improve understanding of the molecular mechanisms of cancer and treatment effects, potentially guiding improvements in diagnosis and therapy.

摘要

在过去20年中,混合成像系统极大地改善了胸部肿瘤患者的护理。正电子发射断层扫描-磁共振成像(PET-MR)系统有进一步改善胸部肿瘤成像的潜力,与目前的磁共振成像和PET-计算机断层扫描系统相比,具有诊断和治疗优势。提高软组织对比度和病变敏感性、改善图像配准、减少辐射暴露以及提高患者便利性是直接的临床优势。PET-MR成像的多参数定量成像能力有潜力增进对癌症分子机制和治疗效果的理解,可能为诊断和治疗的改进提供指导。